Approach to juvenile myasthenic crisis: case report
DOI:
https://doi.org/10.33448/rsd-v10i12.20893Keywords:
Myasthenia; Myasthenic Crisis; Kid; Conduct.Abstract
Introduction: Myasthenia gravis (MG) is an autoimmune disease that affects the neuromuscular junction, the production of antibodies together with the complement system, acts against nicotinic acetylcholine receptors (AChR), located in the postsynaptic membrane, resulting in significant impairment of the neuromuscular transmission. The classic clinical picture presents with fluctuating weakness and fatigability of the ocular, facial, bulbar or limb muscles. Myasthenic crisis, defined as respiratory failure associated with severe muscle weakness, is a potentially fatal complication that occurs in approximately 15%-20% of patients with MG. Objective: to demonstrate the approach to the myasthenic crisis, and the difficulty in diagnosing the myasthenic crisis, improving the prognosis of affected young people, identifying factors that may trigger the onset of symptoms, thus being able to qualify and anticipate the diagnosis of the crisis and treatment, in order to that inadequate procedures do not occur to patients with the disease. Methodology: this is a clinical case study with a qualitative and descriptive perspective, which consists of a research that, in general, takes place with direct data collection, in which the researcher is the indispensable instrument. Case report: This is an 11-year-old female patient, black, with a previous diagnosis of Myasthenia Gravis 6 months ago, with diffuse proximal muscle weakness, admitted for zero vacancy in the emergency care unit of the hospital in question with acute respiratory muscle failure, superficial sedation, administration of fentanyl and midazolam, and she was referred to the intensive care unit, maintaining mechanical ventilation. Conclusion: in view of the case reported, the importance of an accurate diagnosis, quick and effective care is noted, always keeping in mind the stabilization of the crisis, ventilatory support, and specialized pharmacological treatment, using immunoglobulin that showed good efficacy. in the treatment, and having a multidisciplinary team in an intensive care unit, consisting of a respiratory physiotherapist, mainly in respiratory conditions, to offer adequate support for the treatment of rare diseases and better ventilation management in the case of juvenile patients with myasthenia gravis.
References
Castello-Branco, A. C. S., et al. (2011). Atualizações e Perspectivas na Miastenia gravis. Revista Brasileira de Ciências da Saúde, 15 (4), 493-506.
Costa, H. C. R. A. (2016). Miastenia Gravis: aspectos epidemiológicos e evidências sanitárias no Brasil, no período de 2009 a 2013. 2016. 32 f., il. Trabalho de conclusão de curso (Bacharelado em Gestão em Saúde Coletiva) - Universidade de Brasília, Brasília, 2016.
Hughes, B. W., et al. (2006). Arquitetura molecular da junção neuromuscular. Muscle Nerve, 33 (8), 445-461.
Kauling, A. L., et al. (2011). Miastenia Gravis: Relato de Dois Casos e Revisão da Literatura. Revista Brasileira de Anestesiologia, 61 (6), 748-763.
Keesey, J. C. (2002). “Crise” na miastenia gravis: uma perspectiva histórica. Muscle Nerve, 26 (6), 1-3.
Lopez, M. J., et al. (2008). Miastenia grave en la adolescencia: A propósito de un caso. Rev Cubana Med Gen Integr, Ciudad de La Habana, 24 (2), 4-9.
Lorenzoni, P. J., et al. (2011). Myasthenia gravis complicated with cryptococcal meningitis after thymectomy and long-term immunosuppressive therapy. Arquivos de neuro-psiquiatria, 69 (2), 410-411.
Margotto, P. R., et al. (2012). Miastenia grave neonatal: relato de caso. Brasília Med., 49 (1), 66-70.
Marques, L. G., et al. (2020). Miastenia gravis juvenil: Dificuldade diagnóstica na pediatria. Residência Pediátrica, 10 (1), 3-10.
Meriggioli, M. N., et al. (2009). Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol, 8 (5), 475-490.
Ministério da Saúde (2015). Protocolo clínico e Diretrizes Terapêuticas- Miastenia Gravis. http://portalarquivos.saude.go v.br/images/p df/2015/novem bro/2 6/PT-SAS-N---1-169-Miastenia-Gravis-ATUALIZADO-19-11-2015.pdf
Rodrigues, M. M. (2016). Tratado de Neurologia Infantil, Editora Atheneu, 1-1264.
Santos, B. F., et al. (2014). Beneficios de un programa de ejercicio multicomponente de baja intensidad y corta duración en la miastenia gravis. A propósito de un caso. Revista Andaluza de Medicina del Deporte, 7 (4), 178-181.
Scherer, K. et al. (2005). Does this patient have myasthenia gravis? JAMA, 293 (15), 1906-14
Souza, L. M., et al. (2014). Grau de dependência para desenvolver atividades instrumentais da vida diária em adultos com Miastenia Grave. Revista Ampliar, 1 (1), 3-11.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Murilo Henrique Godinho Roque; Bárbara Queiroz de Figueiredo; Iuri Pimenta Oliveira; Mychell Flávio Aparecido Rodrigues de Sousa; Otávio Augusto de Freitas; Vítor Augusto Ferreira Braga; Rúbia Carla Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.